Following its successful contribution to the American Association of Equine Practitioners-led project focused on locomotion ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI(TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

CAMBRIDGE, Mass., April 08, 2026--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac ...

At the 2026 Heart Rhythm Society meeting, researchers presented evidence that AI-powered ECG analysis can detect atrial fibrillation (AF) with over 90% accuracy, even during normal heart rhythm. By ...

This 'dual AI' approach does more than just streamline remote cardiac monitoring workflows; it also reduces alert fatigue by providing clinical teams with highly accurate, trustworthy data. With ...

At the Heart Rhythm Society 2026 meeting, researchers unveiled AI-powered algorithms capable of detecting atrial fibrillation (AF) with over 90% accuracy, even in cases where traditional ECG ...

Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...

Smartwatches, bands and rings are reshaping how Indians track health. Experts explain why wearable data can mislead, when to ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...